ARCH BIOCHEM BIOPHYS 润色咨询

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

出版年份:1951 年文章数:6240 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:2.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=947607, encodeId=2d9094e60717, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;中药活性成分<br>经验分享:从2020年10月底投出去,11月底收到审稿人意见,两位审稿人都提出了中肯的建议,花了两个月补了实验后接收。整个过程花了约3个月时间,杂志的处理速度还是可以的。没有审稿费和版面费,如果选择OA则需额外支付3080刀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/TxSibf7oLxgR5EARZMKjK17z8GR0hJOnBAJnzwF5wvRaDXiaTEvpKt8oSiahAgWgOgJQMTFdXTLWQ0pG68R6iaALvQ/132, createdBy=dbaa5284159, createdName=cy搬运工, createdTime=Fri Mar 12 10:04:50 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒,转头了ABB外审了,希望有个好结果,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087356, encodeId=7a54108e35601, content=方法可以简写到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087355, encodeId=4392108e35527, content=方法部分什么时候需要详细描述,什么时候可以简写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0<br>经验分享:刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074370, encodeId=541d10e437023, content=需提交所有原始数据吗(包括所有柱状图数据)?看投稿须知里没具体写啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Sat Nov 27 00:38:27 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586870, encodeId=00105868e0d7, content=版面费多少钱?<span class="quote">156****1335暂无昵称 2020-03-17 00:00:00 发表:<br>请问大家知道目前一审大概多久不</span>, beContent=156****1335暂无昵称 2020-03-17 00:00:00 发表: 请问大家知道目前一审大概多久不, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588997, encodeId=09d658899e79, content=请问有看到吗?中药单体可以尝试吗<span class="quote">筱哲 2019-03-12 19:51:00 发表:<br>请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?</span>, beContent=筱哲 2019-03-12 19:51:00 发表: 请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 16 00:00:00 CST 2020, time=2020-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586775, encodeId=cbd1586e7522, content=请问大家知道目前一审大概多久不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576100, encodeId=84405e61008e, content=请问版面费多少?<span class="quote">飞速的小鱼 2018-11-03 发表::<br>研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span><span class="quote">飞速的小鱼 2018-11-03 16:35:00 发表:<br>刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span>, beContent=飞速的小鱼 2018-11-03 发表:: 研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f171862141, createdName=ahjxtsh, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=)]
    2021-03-12 cy搬运工

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:肿瘤;中药活性成分
    经验分享:从2020年10月底投出去,11月底收到审稿人意见,两位审稿人都提出了中肯的建议,花了两个月补了实验后接收。整个过程花了约3个月时间,杂志的处理速度还是可以的。没有审稿费和版面费,如果选择OA则需额外支付3080刀。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=947607, encodeId=2d9094e60717, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;中药活性成分<br>经验分享:从2020年10月底投出去,11月底收到审稿人意见,两位审稿人都提出了中肯的建议,花了两个月补了实验后接收。整个过程花了约3个月时间,杂志的处理速度还是可以的。没有审稿费和版面费,如果选择OA则需额外支付3080刀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/TxSibf7oLxgR5EARZMKjK17z8GR0hJOnBAJnzwF5wvRaDXiaTEvpKt8oSiahAgWgOgJQMTFdXTLWQ0pG68R6iaALvQ/132, createdBy=dbaa5284159, createdName=cy搬运工, createdTime=Fri Mar 12 10:04:50 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒,转头了ABB外审了,希望有个好结果,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087356, encodeId=7a54108e35601, content=方法可以简写到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087355, encodeId=4392108e35527, content=方法部分什么时候需要详细描述,什么时候可以简写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0<br>经验分享:刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074370, encodeId=541d10e437023, content=需提交所有原始数据吗(包括所有柱状图数据)?看投稿须知里没具体写啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Sat Nov 27 00:38:27 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586870, encodeId=00105868e0d7, content=版面费多少钱?<span class="quote">156****1335暂无昵称 2020-03-17 00:00:00 发表:<br>请问大家知道目前一审大概多久不</span>, beContent=156****1335暂无昵称 2020-03-17 00:00:00 发表: 请问大家知道目前一审大概多久不, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588997, encodeId=09d658899e79, content=请问有看到吗?中药单体可以尝试吗<span class="quote">筱哲 2019-03-12 19:51:00 发表:<br>请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?</span>, beContent=筱哲 2019-03-12 19:51:00 发表: 请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 16 00:00:00 CST 2020, time=2020-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586775, encodeId=cbd1586e7522, content=请问大家知道目前一审大概多久不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576100, encodeId=84405e61008e, content=请问版面费多少?<span class="quote">飞速的小鱼 2018-11-03 发表::<br>研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span><span class="quote">飞速的小鱼 2018-11-03 16:35:00 发表:<br>刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span>, beContent=飞速的小鱼 2018-11-03 发表:: 研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f171862141, createdName=ahjxtsh, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=)]
    2022-01-27 916603706

    投biomarkers被秒拒,转头了ABB外审了,希望有个好结果,期待

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=947607, encodeId=2d9094e60717, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;中药活性成分<br>经验分享:从2020年10月底投出去,11月底收到审稿人意见,两位审稿人都提出了中肯的建议,花了两个月补了实验后接收。整个过程花了约3个月时间,杂志的处理速度还是可以的。没有审稿费和版面费,如果选择OA则需额外支付3080刀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/TxSibf7oLxgR5EARZMKjK17z8GR0hJOnBAJnzwF5wvRaDXiaTEvpKt8oSiahAgWgOgJQMTFdXTLWQ0pG68R6iaALvQ/132, createdBy=dbaa5284159, createdName=cy搬运工, createdTime=Fri Mar 12 10:04:50 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒,转头了ABB外审了,希望有个好结果,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087356, encodeId=7a54108e35601, content=方法可以简写到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087355, encodeId=4392108e35527, content=方法部分什么时候需要详细描述,什么时候可以简写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0<br>经验分享:刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074370, encodeId=541d10e437023, content=需提交所有原始数据吗(包括所有柱状图数据)?看投稿须知里没具体写啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Sat Nov 27 00:38:27 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586870, encodeId=00105868e0d7, content=版面费多少钱?<span class="quote">156****1335暂无昵称 2020-03-17 00:00:00 发表:<br>请问大家知道目前一审大概多久不</span>, beContent=156****1335暂无昵称 2020-03-17 00:00:00 发表: 请问大家知道目前一审大概多久不, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588997, encodeId=09d658899e79, content=请问有看到吗?中药单体可以尝试吗<span class="quote">筱哲 2019-03-12 19:51:00 发表:<br>请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?</span>, beContent=筱哲 2019-03-12 19:51:00 发表: 请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 16 00:00:00 CST 2020, time=2020-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586775, encodeId=cbd1586e7522, content=请问大家知道目前一审大概多久不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576100, encodeId=84405e61008e, content=请问版面费多少?<span class="quote">飞速的小鱼 2018-11-03 发表::<br>研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span><span class="quote">飞速的小鱼 2018-11-03 16:35:00 发表:<br>刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span>, beContent=飞速的小鱼 2018-11-03 发表:: 研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f171862141, createdName=ahjxtsh, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=)]
    2021-12-28 MS54455111222

    方法可以简写到什么程度?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=947607, encodeId=2d9094e60717, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;中药活性成分<br>经验分享:从2020年10月底投出去,11月底收到审稿人意见,两位审稿人都提出了中肯的建议,花了两个月补了实验后接收。整个过程花了约3个月时间,杂志的处理速度还是可以的。没有审稿费和版面费,如果选择OA则需额外支付3080刀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/TxSibf7oLxgR5EARZMKjK17z8GR0hJOnBAJnzwF5wvRaDXiaTEvpKt8oSiahAgWgOgJQMTFdXTLWQ0pG68R6iaALvQ/132, createdBy=dbaa5284159, createdName=cy搬运工, createdTime=Fri Mar 12 10:04:50 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒,转头了ABB外审了,希望有个好结果,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087356, encodeId=7a54108e35601, content=方法可以简写到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087355, encodeId=4392108e35527, content=方法部分什么时候需要详细描述,什么时候可以简写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0<br>经验分享:刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074370, encodeId=541d10e437023, content=需提交所有原始数据吗(包括所有柱状图数据)?看投稿须知里没具体写啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Sat Nov 27 00:38:27 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586870, encodeId=00105868e0d7, content=版面费多少钱?<span class="quote">156****1335暂无昵称 2020-03-17 00:00:00 发表:<br>请问大家知道目前一审大概多久不</span>, beContent=156****1335暂无昵称 2020-03-17 00:00:00 发表: 请问大家知道目前一审大概多久不, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588997, encodeId=09d658899e79, content=请问有看到吗?中药单体可以尝试吗<span class="quote">筱哲 2019-03-12 19:51:00 发表:<br>请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?</span>, beContent=筱哲 2019-03-12 19:51:00 发表: 请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 16 00:00:00 CST 2020, time=2020-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586775, encodeId=cbd1586e7522, content=请问大家知道目前一审大概多久不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576100, encodeId=84405e61008e, content=请问版面费多少?<span class="quote">飞速的小鱼 2018-11-03 发表::<br>研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span><span class="quote">飞速的小鱼 2018-11-03 16:35:00 发表:<br>刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span>, beContent=飞速的小鱼 2018-11-03 发表:: 研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f171862141, createdName=ahjxtsh, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=)]
    2021-12-27 Mia

    方法部分什么时候需要详细描述,什么时候可以简写?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=947607, encodeId=2d9094e60717, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;中药活性成分<br>经验分享:从2020年10月底投出去,11月底收到审稿人意见,两位审稿人都提出了中肯的建议,花了两个月补了实验后接收。整个过程花了约3个月时间,杂志的处理速度还是可以的。没有审稿费和版面费,如果选择OA则需额外支付3080刀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/TxSibf7oLxgR5EARZMKjK17z8GR0hJOnBAJnzwF5wvRaDXiaTEvpKt8oSiahAgWgOgJQMTFdXTLWQ0pG68R6iaALvQ/132, createdBy=dbaa5284159, createdName=cy搬运工, createdTime=Fri Mar 12 10:04:50 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒,转头了ABB外审了,希望有个好结果,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087356, encodeId=7a54108e35601, content=方法可以简写到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087355, encodeId=4392108e35527, content=方法部分什么时候需要详细描述,什么时候可以简写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0<br>经验分享:刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074370, encodeId=541d10e437023, content=需提交所有原始数据吗(包括所有柱状图数据)?看投稿须知里没具体写啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Sat Nov 27 00:38:27 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586870, encodeId=00105868e0d7, content=版面费多少钱?<span class="quote">156****1335暂无昵称 2020-03-17 00:00:00 发表:<br>请问大家知道目前一审大概多久不</span>, beContent=156****1335暂无昵称 2020-03-17 00:00:00 发表: 请问大家知道目前一审大概多久不, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588997, encodeId=09d658899e79, content=请问有看到吗?中药单体可以尝试吗<span class="quote">筱哲 2019-03-12 19:51:00 发表:<br>请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?</span>, beContent=筱哲 2019-03-12 19:51:00 发表: 请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 16 00:00:00 CST 2020, time=2020-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586775, encodeId=cbd1586e7522, content=请问大家知道目前一审大概多久不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576100, encodeId=84405e61008e, content=请问版面费多少?<span class="quote">飞速的小鱼 2018-11-03 发表::<br>研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span><span class="quote">飞速的小鱼 2018-11-03 16:35:00 发表:<br>刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span>, beContent=飞速的小鱼 2018-11-03 发表:: 研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f171862141, createdName=ahjxtsh, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=)]
    2018-11-03 飞速的小鱼1657

    审稿速度:1.0
    经验分享:刚在本刊发表论文一篇,跟大家分享一下投稿经历:
    从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。

    4

    展开4条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=947607, encodeId=2d9094e60717, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;中药活性成分<br>经验分享:从2020年10月底投出去,11月底收到审稿人意见,两位审稿人都提出了中肯的建议,花了两个月补了实验后接收。整个过程花了约3个月时间,杂志的处理速度还是可以的。没有审稿费和版面费,如果选择OA则需额外支付3080刀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/TxSibf7oLxgR5EARZMKjK17z8GR0hJOnBAJnzwF5wvRaDXiaTEvpKt8oSiahAgWgOgJQMTFdXTLWQ0pG68R6iaALvQ/132, createdBy=dbaa5284159, createdName=cy搬运工, createdTime=Fri Mar 12 10:04:50 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒,转头了ABB外审了,希望有个好结果,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087356, encodeId=7a54108e35601, content=方法可以简写到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087355, encodeId=4392108e35527, content=方法部分什么时候需要详细描述,什么时候可以简写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0<br>经验分享:刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074370, encodeId=541d10e437023, content=需提交所有原始数据吗(包括所有柱状图数据)?看投稿须知里没具体写啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Sat Nov 27 00:38:27 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586870, encodeId=00105868e0d7, content=版面费多少钱?<span class="quote">156****1335暂无昵称 2020-03-17 00:00:00 发表:<br>请问大家知道目前一审大概多久不</span>, beContent=156****1335暂无昵称 2020-03-17 00:00:00 发表: 请问大家知道目前一审大概多久不, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588997, encodeId=09d658899e79, content=请问有看到吗?中药单体可以尝试吗<span class="quote">筱哲 2019-03-12 19:51:00 发表:<br>请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?</span>, beContent=筱哲 2019-03-12 19:51:00 发表: 请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 16 00:00:00 CST 2020, time=2020-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586775, encodeId=cbd1586e7522, content=请问大家知道目前一审大概多久不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576100, encodeId=84405e61008e, content=请问版面费多少?<span class="quote">飞速的小鱼 2018-11-03 发表::<br>研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span><span class="quote">飞速的小鱼 2018-11-03 16:35:00 发表:<br>刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span>, beContent=飞速的小鱼 2018-11-03 发表:: 研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f171862141, createdName=ahjxtsh, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=)]
    2021-11-27 916603706

    需提交所有原始数据吗(包括所有柱状图数据)?看投稿须知里没具体写啊

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=947607, encodeId=2d9094e60717, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;中药活性成分<br>经验分享:从2020年10月底投出去,11月底收到审稿人意见,两位审稿人都提出了中肯的建议,花了两个月补了实验后接收。整个过程花了约3个月时间,杂志的处理速度还是可以的。没有审稿费和版面费,如果选择OA则需额外支付3080刀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/TxSibf7oLxgR5EARZMKjK17z8GR0hJOnBAJnzwF5wvRaDXiaTEvpKt8oSiahAgWgOgJQMTFdXTLWQ0pG68R6iaALvQ/132, createdBy=dbaa5284159, createdName=cy搬运工, createdTime=Fri Mar 12 10:04:50 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒,转头了ABB外审了,希望有个好结果,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087356, encodeId=7a54108e35601, content=方法可以简写到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087355, encodeId=4392108e35527, content=方法部分什么时候需要详细描述,什么时候可以简写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0<br>经验分享:刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074370, encodeId=541d10e437023, content=需提交所有原始数据吗(包括所有柱状图数据)?看投稿须知里没具体写啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Sat Nov 27 00:38:27 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586870, encodeId=00105868e0d7, content=版面费多少钱?<span class="quote">156****1335暂无昵称 2020-03-17 00:00:00 发表:<br>请问大家知道目前一审大概多久不</span>, beContent=156****1335暂无昵称 2020-03-17 00:00:00 发表: 请问大家知道目前一审大概多久不, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588997, encodeId=09d658899e79, content=请问有看到吗?中药单体可以尝试吗<span class="quote">筱哲 2019-03-12 19:51:00 发表:<br>请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?</span>, beContent=筱哲 2019-03-12 19:51:00 发表: 请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 16 00:00:00 CST 2020, time=2020-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586775, encodeId=cbd1586e7522, content=请问大家知道目前一审大概多久不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576100, encodeId=84405e61008e, content=请问版面费多少?<span class="quote">飞速的小鱼 2018-11-03 发表::<br>研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span><span class="quote">飞速的小鱼 2018-11-03 16:35:00 发表:<br>刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span>, beContent=飞速的小鱼 2018-11-03 发表:: 研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f171862141, createdName=ahjxtsh, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=)]
    2020-03-18 肥皂冒泡

    版面费多少钱?156****1335暂无昵称 2020-03-17 00:00:00 发表:
    请问大家知道目前一审大概多久不

    156****1335暂无昵称 2020-03-17 00:00:00 发表: 请问大家知道目前一审大概多久不

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=947607, encodeId=2d9094e60717, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;中药活性成分<br>经验分享:从2020年10月底投出去,11月底收到审稿人意见,两位审稿人都提出了中肯的建议,花了两个月补了实验后接收。整个过程花了约3个月时间,杂志的处理速度还是可以的。没有审稿费和版面费,如果选择OA则需额外支付3080刀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/TxSibf7oLxgR5EARZMKjK17z8GR0hJOnBAJnzwF5wvRaDXiaTEvpKt8oSiahAgWgOgJQMTFdXTLWQ0pG68R6iaALvQ/132, createdBy=dbaa5284159, createdName=cy搬运工, createdTime=Fri Mar 12 10:04:50 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒,转头了ABB外审了,希望有个好结果,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087356, encodeId=7a54108e35601, content=方法可以简写到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087355, encodeId=4392108e35527, content=方法部分什么时候需要详细描述,什么时候可以简写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0<br>经验分享:刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074370, encodeId=541d10e437023, content=需提交所有原始数据吗(包括所有柱状图数据)?看投稿须知里没具体写啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Sat Nov 27 00:38:27 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586870, encodeId=00105868e0d7, content=版面费多少钱?<span class="quote">156****1335暂无昵称 2020-03-17 00:00:00 发表:<br>请问大家知道目前一审大概多久不</span>, beContent=156****1335暂无昵称 2020-03-17 00:00:00 发表: 请问大家知道目前一审大概多久不, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588997, encodeId=09d658899e79, content=请问有看到吗?中药单体可以尝试吗<span class="quote">筱哲 2019-03-12 19:51:00 发表:<br>请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?</span>, beContent=筱哲 2019-03-12 19:51:00 发表: 请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 16 00:00:00 CST 2020, time=2020-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586775, encodeId=cbd1586e7522, content=请问大家知道目前一审大概多久不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576100, encodeId=84405e61008e, content=请问版面费多少?<span class="quote">飞速的小鱼 2018-11-03 发表::<br>研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span><span class="quote">飞速的小鱼 2018-11-03 16:35:00 发表:<br>刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span>, beContent=飞速的小鱼 2018-11-03 发表:: 研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f171862141, createdName=ahjxtsh, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=)]
    2020-04-16 Miss 懵

    请问有看到吗?中药单体可以尝试吗筱哲 2019-03-12 19:51:00 发表:
    请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?

    筱哲 2019-03-12 19:51:00 发表: 请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=947607, encodeId=2d9094e60717, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;中药活性成分<br>经验分享:从2020年10月底投出去,11月底收到审稿人意见,两位审稿人都提出了中肯的建议,花了两个月补了实验后接收。整个过程花了约3个月时间,杂志的处理速度还是可以的。没有审稿费和版面费,如果选择OA则需额外支付3080刀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/TxSibf7oLxgR5EARZMKjK17z8GR0hJOnBAJnzwF5wvRaDXiaTEvpKt8oSiahAgWgOgJQMTFdXTLWQ0pG68R6iaALvQ/132, createdBy=dbaa5284159, createdName=cy搬运工, createdTime=Fri Mar 12 10:04:50 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒,转头了ABB外审了,希望有个好结果,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087356, encodeId=7a54108e35601, content=方法可以简写到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087355, encodeId=4392108e35527, content=方法部分什么时候需要详细描述,什么时候可以简写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0<br>经验分享:刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074370, encodeId=541d10e437023, content=需提交所有原始数据吗(包括所有柱状图数据)?看投稿须知里没具体写啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Sat Nov 27 00:38:27 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586870, encodeId=00105868e0d7, content=版面费多少钱?<span class="quote">156****1335暂无昵称 2020-03-17 00:00:00 发表:<br>请问大家知道目前一审大概多久不</span>, beContent=156****1335暂无昵称 2020-03-17 00:00:00 发表: 请问大家知道目前一审大概多久不, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588997, encodeId=09d658899e79, content=请问有看到吗?中药单体可以尝试吗<span class="quote">筱哲 2019-03-12 19:51:00 发表:<br>请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?</span>, beContent=筱哲 2019-03-12 19:51:00 发表: 请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 16 00:00:00 CST 2020, time=2020-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586775, encodeId=cbd1586e7522, content=请问大家知道目前一审大概多久不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576100, encodeId=84405e61008e, content=请问版面费多少?<span class="quote">飞速的小鱼 2018-11-03 发表::<br>研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span><span class="quote">飞速的小鱼 2018-11-03 16:35:00 发表:<br>刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span>, beContent=飞速的小鱼 2018-11-03 发表:: 研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f171862141, createdName=ahjxtsh, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=)]
    2020-03-17 147f9deem35暂无昵称

    请问大家知道目前一审大概多久不

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=947607, encodeId=2d9094e60717, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;中药活性成分<br>经验分享:从2020年10月底投出去,11月底收到审稿人意见,两位审稿人都提出了中肯的建议,花了两个月补了实验后接收。整个过程花了约3个月时间,杂志的处理速度还是可以的。没有审稿费和版面费,如果选择OA则需额外支付3080刀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/TxSibf7oLxgR5EARZMKjK17z8GR0hJOnBAJnzwF5wvRaDXiaTEvpKt8oSiahAgWgOgJQMTFdXTLWQ0pG68R6iaALvQ/132, createdBy=dbaa5284159, createdName=cy搬运工, createdTime=Fri Mar 12 10:04:50 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒,转头了ABB外审了,希望有个好结果,期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087356, encodeId=7a54108e35601, content=方法可以简写到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087355, encodeId=4392108e35527, content=方法部分什么时候需要详细描述,什么时候可以简写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0<br>经验分享:刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074370, encodeId=541d10e437023, content=需提交所有原始数据吗(包括所有柱状图数据)?看投稿须知里没具体写啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Sat Nov 27 00:38:27 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586870, encodeId=00105868e0d7, content=版面费多少钱?<span class="quote">156****1335暂无昵称 2020-03-17 00:00:00 发表:<br>请问大家知道目前一审大概多久不</span>, beContent=156****1335暂无昵称 2020-03-17 00:00:00 发表: 请问大家知道目前一审大概多久不, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588997, encodeId=09d658899e79, content=请问有看到吗?中药单体可以尝试吗<span class="quote">筱哲 2019-03-12 19:51:00 发表:<br>请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?</span>, beContent=筱哲 2019-03-12 19:51:00 发表: 请问各位大侠们,有没有人投稿中医药类的或者中医复方治疗肿瘤类的文章呀,这个杂志接受这些吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 16 00:00:00 CST 2020, time=2020-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586775, encodeId=cbd1586e7522, content=请问大家知道目前一审大概多久不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576100, encodeId=84405e61008e, content=请问版面费多少?<span class="quote">飞速的小鱼 2018-11-03 发表::<br>研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span><span class="quote">飞速的小鱼 2018-11-03 16:35:00 发表:<br>刚在本刊发表论文一篇,跟大家分享一下投稿经历: <br> 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。</span>, beContent=飞速的小鱼 2018-11-03 发表:: 研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f171862141, createdName=ahjxtsh, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=)]
    2019-09-10 ahjxtsh

    请问版面费多少?飞速的小鱼 2018-11-03 发表::
    研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。
    飞速的小鱼 2018-11-03 16:35:00 发表:
    刚在本刊发表论文一篇,跟大家分享一下投稿经历:
    从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。

    飞速的小鱼 2018-11-03 发表:: 研究方向:干细胞;心脏病; 审稿时间:约1个月 刚在本刊发表论文一篇,跟大家分享一下投稿经历: 从投稿到online总共4个月,审稿很快,一审2周,major revision, 两个审稿人提的意见都很好,editor给了2个月时间返修,按照reviewers的意见补充实验,时间不太够,给editor写信请求多给半个月时间,editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志,而且效率很高。

    0

共75条页码: 2/8页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分